The case for a ketogenic diet in the management of kidney disease

SJ Athinarayanan, CGP Roberts, C Vangala… - BMJ Open Diabetes …, 2024 - drc.bmj.com
Ketogenic diets have been widely used for weight loss and are increasingly used in the
management of type 2 diabetes. Despite evidence that ketones have multiple positive effects …

[HTML][HTML] Therapeutic Potential of Ketogenic Interventions for Autosomal-Dominant Polycystic Kidney Disease: A Systematic Review

D Li, J Dawson, JE Gunton - Nutrients, 2024 - mdpi.com
Background: Recent findings have highlighted that abnormal energy metabolism is a key
feature of autosomal-dominant polycystic kidney disease (ADPKD). Emerging evidence …

[HTML][HTML] β-hydroxybutyrate recapitulates the beneficial effects of ketogenic metabolic therapy in polycystic kidney disease

JA Torres, N Holznecht, DA Asplund, BC Kroes… - Iscience, 2024 - cell.com
Autosomal-dominant polycystic kidney disease (ADPKD) is a common monogenic disease
characterized by the formation of fluid-filled renal cysts, loss of mitochondrial function …

[HTML][HTML] Ketogenic Interventions in Autosomal Dominant Polycystic Kidney Disease: A Comprehensive Review of Current Evidence

C Pezzuoli, G Biagini, R Magistroni - Nutrients, 2024 - mdpi.com
Autosomal Dominant Polycystic Kidney Disease (ADPKD) is a genetic disorder
characterized by the development and enlargement of multiple kidney cysts, leading to …

[HTML][HTML] Trigger Warning: How Modern Diet, Lifestyle, and Environment Pull the Trigger on Autosomal Dominant Polycystic Kidney Disease Progression

M Messing, JA Torres, N Holznecht, T Weimbs - Nutrients, 2024 - pmc.ncbi.nlm.nih.gov
Understanding chronic kidney disease (CKD) through the lens of evolutionary biology
highlights the mismatch between our Paleolithic-optimized genes and modern diets, which …

Citrate in autosomal dominant polycystic kidney disease: biomarker or therapeutic agent?

DR Rocha, ACC Matos, IP Heilberg - Current Opinion in Nephrology and … - journals.lww.com
Citrate in autosomal dominant polycystic kidney disease: biomarker or therapeutic agent? Page 1
MNH 340204 CURRENT OPINION Citrate in autosomal dominant polycystic kidney disease …